Valbenazine improves quality of life, functionality, and movement severity in patients with tardive dyskinesia: findings from the KINECT-PRO™ study

Christoph U. Correll, M. Mercedes Perez-Rodriguez, Joseph P. McEvoy, David V. Sheehan, Gustavo Alva, Susan Mathias, Morgan Bron, Robert H. Farber, Hui Zhang, Eduardo Dunayevich, Ashok Parameswaran

Open source

DOI: 10.1017/s1092852926101138
Published: 2026
Container: CNS Spectrums
Publisher: Cambridge University Press (CUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1017/s1092852926101138,
  title = {Valbenazine improves quality of life, functionality, and movement severity in patients with tardive dyskinesia: findings from the KINECT-PRO™ study},
  author = {Christoph U. Correll and M. Mercedes Perez-Rodriguez and Joseph P. McEvoy and David V. Sheehan and Gustavo Alva and Susan Mathias and Morgan Bron and Robert H. Farber and Hui Zhang and Eduardo Dunayevich and Ashok Parameswaran},
  year = {2026},
  journal = {CNS Spectrums},
  doi = {10.1017/s1092852926101138},
  url = {https://doi.org/10.1017/s1092852926101138}
}

RIS

TY  - JOUR
TI  - Valbenazine improves quality of life, functionality, and movement severity in patients with tardive dyskinesia: findings from the KINECT-PRO™ study
AU  - Christoph U. Correll
AU  - M. Mercedes Perez-Rodriguez
AU  - Joseph P. McEvoy
AU  - David V. Sheehan
AU  - Gustavo Alva
AU  - Susan Mathias
AU  - Morgan Bron
AU  - Robert H. Farber
AU  - Hui Zhang
AU  - Eduardo Dunayevich
AU  - Ashok Parameswaran
PY  - 2026
JO  - CNS Spectrums
DO  - 10.1017/s1092852926101138
UR  - https://doi.org/10.1017/s1092852926101138
ER  -

APA

Correll, C. U., Perez-Rodriguez, M. M., McEvoy, J. P., Sheehan, D. V., Alva, G., Mathias, S., Bron, M., Farber, R. H., Zhang, H., Dunayevich, E., & Parameswaran, A. (2026). Valbenazine improves quality of life, functionality, and movement severity in patients with tardive dyskinesia: findings from the KINECT-PRO™ study. CNS Spectrums. https://doi.org/10.1017/s1092852926101138

Source records

crossref · retrieved 2026-09-25T17:49:04.755Z